Co-investment
Royalty Pharma Offers US$6.6Bln Offer for Elan
Royalty Pharma offers US$11 per Elan share. While Elan is in the process of selling its fifty percent share in the successful multiple scelerosis drug Tysabri with its US partner Biogen Idec, here comes American investment firm Royalty Pharma offering US6.
ABRY Raises Stake in Datapipe
ABRY has been raising its stake in data center provider Datapipe as it makes investments out of its private equity fund.
News Corp., Walt Disney in Talks About Hulu's Fate
Both News Corp. and Walt Disney have been discussions how to settle issuing badly affecting its jointly controlled online video site Hulu LLC.
Control of Hulu under Discussion
Disney and News Corp are in discussions as to the future of Hulu.com Discussions are now ongoing for the control of Hulu. com, the website partners News Corp and Walt Disney Co currently co-own.